גאלבוס 50 מ"ג

Land: Israel

Språk: hebraisk

Kilde: Ministry of Health

Kjøp det nå

Aktiv ingrediens:

VILDAGLIPTIN 50 MG

Tilgjengelig fra:

NOVARTIS PHARMA SERVICES AG

ATC-kode:

A10BH02

Legemiddelform:

TABLETS

Administreringsrute:

PER OS

Produsert av:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

Terapeutisk gruppe:

VILDAGLIPTIN

Indikasjoner:

Galvus is indicated as an adjunct to diet and exercise in patients with type 2 diabetes mellitus• As monotherapy, if diet and exercise are not sufficient, or• In combination with metformin, or a sulfonylurea if treatment with these oral antidiabetics does not offer sufficient control of blood glucose.As triple oral therapy in combination with• a sulphonylurea and metformin when diet and exercise plus dual therapy with these agents do not provide adequate glycaemic control. Galvus is also indicated for use in combination with insulin (with or without metformin) when diet and exercise plus a stable dose of insulin do not provide adequate glycaemic control.

Autorisasjon dato:

2008-12-01

Søk varsler relatert til dette produktet